OXB to Provide Process Development, GMP Services to Plowshare in New Deal

04:36 AM EDT, 07/16/2026 (MT Newswires) -- Oxford Biomedica (OXB.L), or OXB, will provide process development and adeno-associated virus good manufacturing practice, or GMP, services to Plowshare Therapies under a new agreement. The cell and gene therapy company said Thursday that Plowshare's program will be supported from its commercial-scale viral vector manufacturing facility in the city of Durham, North Carolina, US. OXB may also support additional programs and later-stage manufacturing as Plowshare's pipeline advances.